Showing results (451-460 of 543) with videos related to
Sort By:
Pageof 55
Hamostaseologie|February 5, 2003
[The national GTH haemophilia registry as database within the scope of the German human genome project]H Krebs, C Domsch, K Adelhard, et al.Anesthesiology|December 1, 1990
Influence of high-dose aprotinin treatment on blood loss and coagulation patterns in patients undergoing myocardial revascularizationW Dietrich, M Spannagl, M Jochum, et al.Experimental Hematology|December 9, 1998
Antibodies TC-12 ("unique") and TH-111 (CD96) characterize T-cell acute lymphoblastic leukemia and a subgroup of acute myeloid leukemiaM Gramatzki, W D Ludwig, R Burger, et al.Hamostaseologie|February 5, 2003
[2% Haemophilia A patients without mutation in the FVIII gene]C Uen, J Oldenburg, J Schröder, et al.Hamostaseologie|February 5, 2003
[Characterization of factor VIII antibody epitopes from haemophilia A patients using cellulose bound FVIII peptide libraries]T Albert, S Lange, J Oldenburg, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|February 6, 2008
European principles of haemophilia careB T Colvin, J Astermark, K Fischer, et al.Contraception|January 12, 1999
Normalized activated protein C ratio itself not associated with increased risk of venous thromboembolismL A Heinemann, A Assmann, M Spannagl, et al.Archives of Environmental Contamination and Toxicology|October 25, 2006
Effects of a branched p-nonylphenol isomer (4(3',6'-dimethyl-3'-heptyl)-phenol) on embryogenesis in Lymnae stagnalis LJ O Lalah, G F Severin, K-W Schramm, et al.Immunobiology|May 1, 1998
Lack of protection from HIV infection by the mutant HIV coreceptor CCR5 in intravenously HIV infected hemophilia patientsA Malo, F Rommel, J Bogner, et al.Archives of Dermatology|June 1, 1993
Treatment of coumarin-induced skin necrosis with a monoclonal antibody purified protein C concentrateW Schramm, M Spannagl, K A Bauer, et al.Pageof 55